[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2806303B1 - Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments - Google Patents

Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments

Info

Publication number
FR2806303B1
FR2806303B1 FR0003430A FR0003430A FR2806303B1 FR 2806303 B1 FR2806303 B1 FR 2806303B1 FR 0003430 A FR0003430 A FR 0003430A FR 0003430 A FR0003430 A FR 0003430A FR 2806303 B1 FR2806303 B1 FR 2806303B1
Authority
FR
France
Prior art keywords
cytosquelet
medicaments
manufacture
applications
elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0003430A
Other languages
English (en)
Other versions
FR2806303A1 (fr
Inventor
Etienne Emile Baulieu
Paul Robel
Esther Fellous
Koichi Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0003430A priority Critical patent/FR2806303B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to AU2001244271A priority patent/AU2001244271A1/en
Priority to EP01917179A priority patent/EP1263419A2/fr
Priority to PCT/FR2001/000816 priority patent/WO2001068068A2/fr
Priority to US10/221,862 priority patent/US20030125311A1/en
Priority to CA002403420A priority patent/CA2403420A1/fr
Publication of FR2806303A1 publication Critical patent/FR2806303A1/fr
Application granted granted Critical
Publication of FR2806303B1 publication Critical patent/FR2806303B1/fr
Priority to US11/090,072 priority patent/US20050197322A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0003430A 2000-03-17 2000-03-17 Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments Expired - Fee Related FR2806303B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0003430A FR2806303B1 (fr) 2000-03-17 2000-03-17 Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
EP01917179A EP1263419A2 (fr) 2000-03-17 2001-03-19 Composes se liant au cytosquelette
PCT/FR2001/000816 WO2001068068A2 (fr) 2000-03-17 2001-03-19 Composes se liant au cytosquelette
US10/221,862 US20030125311A1 (en) 2000-03-17 2001-03-19 Compounds capable of binding with the cytoskeleton
AU2001244271A AU2001244271A1 (en) 2000-03-17 2001-03-19 Compounds capable of binding with the cytoskeleton
CA002403420A CA2403420A1 (fr) 2000-03-17 2001-03-19 Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
US11/090,072 US20050197322A1 (en) 2000-03-17 2005-03-28 Compounds capable of binding to proteins constituting or associated with cytoskeletal elements, and their applications for the manufacture of medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003430A FR2806303B1 (fr) 2000-03-17 2000-03-17 Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments

Publications (2)

Publication Number Publication Date
FR2806303A1 FR2806303A1 (fr) 2001-09-21
FR2806303B1 true FR2806303B1 (fr) 2002-09-27

Family

ID=8848200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0003430A Expired - Fee Related FR2806303B1 (fr) 2000-03-17 2000-03-17 Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments

Country Status (5)

Country Link
EP (1) EP1263419A2 (fr)
AU (1) AU2001244271A1 (fr)
CA (1) CA2403420A1 (fr)
FR (1) FR2806303B1 (fr)
WO (1) WO2001068068A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9339508B2 (en) 2003-01-17 2016-05-17 Mapreg Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury
FR2850023B1 (fr) * 2003-01-17 2007-04-06 Mapreg Medicaments pour le systeme nerveux
EP1812009B1 (fr) * 2004-11-18 2013-05-15 Umecrine AB Antagonistes des steroides gaba et leur utilisation dans le traitement des troubles du snc

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525535A (ja) * 1997-09-04 2001-12-11 ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ 細胞骨格機能のモジュレーターを検出するためのアッセイ
ES2310943T3 (es) * 1998-06-10 2009-01-16 Sterix Limited Composicion farmaceutica con factor de necrosis tumoral a y 2-metoxiestrona-3-o-sulfamato para la inhibicion de la estrona sulfatasa.
WO2000026229A1 (fr) * 1998-10-29 2000-05-11 Teikoku Hormone Mfg. Co., Ltd. Derives de 2-substitues-d-homooxasteroides
AU5276300A (en) * 1999-05-21 2000-12-12 University Of Hawaii Taccalonolide microtubule stabilizing agents

Also Published As

Publication number Publication date
WO2001068068A2 (fr) 2001-09-20
AU2001244271A1 (en) 2001-09-24
CA2403420A1 (fr) 2001-09-20
EP1263419A2 (fr) 2002-12-11
WO2001068068A3 (fr) 2002-06-20
FR2806303A1 (fr) 2001-09-21

Similar Documents

Publication Publication Date Title
ATE287924T1 (de) Multimodal polyethylenmaterial
DE10297191T5 (de) Phase-Change-Material-Speicherbauteil
DE60226285D1 (de) Kupplungskalibrierung und -steuerung
DE60239174D1 (de) Feuchtigkeitssensor
DE60137031D1 (de) Verpackungsmaterial und verpackungsgegenstand
NO20041328L (no) Innkapslede materialer
AU2002345013A1 (en) Tiered control architecture for material handling
FR2813987B1 (fr) Microcomposant du type micro-inductance ou micro-transformateur
EP1399215A4 (fr) Proteines membranaires endotheliales a specificite tissulaire
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
FR2829142B1 (fr) Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues
ATE219443T1 (de) Wiederverschliessbares ausgiesselement und damit versehene flachgiebelverbundpackung
AU2532901A (en) Measurement of flow characteristics of fluent material
DE60114295D1 (de) Redispergierbares synthetisches Harzpulver und Verwendung davon
DE60005446D1 (de) Flüssigkeitsbeständiger Mehrschichtwerkstoff
FR2806303B1 (fr) Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
NO20042693L (no) Kateterpreparat og anvendelser derav
FR2827292B1 (fr) Photoproteines mutees et leurs applications
ATE312062T1 (de) Baumaterial
DE60223474D1 (de) Dichtungsmaterial
FR2811135B1 (fr) Microcomposant du type micro-inductance ou microtransformateur
FR2857014B1 (fr) Peptides chelatant l'uranium et leurs applications
NO20014610L (no) Måling og styring av strömmen av flytbare materialer
DE60014616D1 (de) Antikörper gegen plazentaprotein 13
ES1049221Y (es) Caja plegable y apilable.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20061130